Inside Karl Pringle's plan to disrupt the centuries-old approach to drug therapy — and save thousands of lives in the process

The CEO of GenXys on how his startup — through science and software — will put an end to one-size-fits-all treatments and bring prescriptions into the future.

Karl Pringle, the chief executive of GenXys, was on the other end of my Zoom call, and he was incredulous. No, actually, he was just worked up; I’m the one who was incredulous. He had just told me that 50% of drug therapies don't work as expected. I researched this later and also learned from the CDC that half of all prescriptions are taken incorrectly …